Abstract

Selective autophagy is mediated by cargo receptors that link the cargo to the isolation membrane via interactions with Atg8 proteins. Atg8 proteins are localized to the membrane in an ubiquitin-like conjugation reaction, but how this conjugation is coupled to the presence of the cargo is unclear. Here we show that the S. cerevisiae Atg19, Atg34 and the human p62, Optineurin and NDP52 cargo receptors interact with the E3-like enzyme Atg12∼Atg5-Atg16, which stimulates Atg8 conjugation. The interaction of Atg19 with the Atg12∼Atg5-Atg16 complex is mediated by its Atg8-interacting motifs (AIMs). We identify the AIM-binding sites in the Atg5 subunit and mutation of these sites impairs selective autophagy. In a reconstituted system the recruitment of the E3 to the prApe1 cargo is sufficient to drive accumulation of conjugated Atg8 at the cargo. The interaction of the Atg12∼Atg5-Atg16 complex and Atg8 with Atg19 is mutually exclusive, which may confer directionality to the system.

Article and author information

Author details

  1. Dorotea Fracchiolla

    Department of Biochemistry and Cell Biology, University of Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  2. Justyna Sawa-Makarska

    Department of Biochemistry and Cell Biology, University of Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  3. Bettina Zens

    Department of Biochemistry and Cell Biology, University of Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  4. Anita de Ruiter

    Department of Structural and Computational Biology, University of Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  5. Gabriele Zaffagnini

    Department of Structural and Computational Biology, University of Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  6. Andrea Brezovich

    Department of Biochemistry and Cell Biology, University of Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  7. Julia Romanov

    Department of Biochemistry and Cell Biology, University of Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  8. Kathrin Runggatscher

    Department of Biochemistry and Cell Biology, University of Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  9. Claudine Kraft

    Department of Biochemistry and Cell Biology, University of Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  10. Bojan Zagrovic

    Department of Structural and Computational Biology, University of Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  11. Sascha Martens

    Department of Biochemistry and Cell Biology, University of Vienna, Vienna, Austria
    For correspondence
    sascha.martens@univie.ac.at
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3786-8199

Funding

European Research Council (260304)

  • Sascha Martens

European Research Council (646653)

  • Sascha Martens

European Research Council (279408)

  • Bojan Zagrovic

Austrian Science Fund (P25546-B20)

  • Sascha Martens

Austrian Science Fund (P25522-B20)

  • Claudine Kraft

Austrian Science Fund (P28113-B28)

  • Claudine Kraft

Austrian Science Fund (T724-B20)

  • Justyna Sawa-Makarska

Vienna Science and Technology Fund (VRG10-791 001)

  • Claudine Kraft

European Molecular Biology Organization (YIP)

  • Claudine Kraft
  • Sascha Martens

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2016, Fracchiolla et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,389
    views
  • 1,061
    downloads
  • 59
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Dorotea Fracchiolla
  2. Justyna Sawa-Makarska
  3. Bettina Zens
  4. Anita de Ruiter
  5. Gabriele Zaffagnini
  6. Andrea Brezovich
  7. Julia Romanov
  8. Kathrin Runggatscher
  9. Claudine Kraft
  10. Bojan Zagrovic
  11. Sascha Martens
(2016)
Mechanism of cargo-directed Atg8 conjugation during selective autophagy
eLife 5:e18544.
https://doi.org/10.7554/eLife.18544

Share this article

https://doi.org/10.7554/eLife.18544

Further reading

    1. Biochemistry and Chemical Biology
    2. Computational and Systems Biology
    A Sofia F Oliveira, Fiona L Kearns ... Adrian J Mulholland
    Short Report

    The spike protein is essential to the SARS-CoV-2 virus life cycle, facilitating virus entry and mediating viral-host membrane fusion. The spike contains a fatty acid (FA) binding site between every two neighbouring receptor-binding domains. This site is coupled to key regions in the protein, but the impact of glycans on these allosteric effects has not been investigated. Using dynamical nonequilibrium molecular dynamics (D-NEMD) simulations, we explore the allosteric effects of the FA site in the fully glycosylated spike of the SARS-CoV-2 ancestral variant. Our results identify the allosteric networks connecting the FA site to functionally important regions in the protein, including the receptor-binding motif, an antigenic supersite in the N-terminal domain, the fusion peptide region, and another allosteric site known to bind heme and biliverdin. The networks identified here highlight the complexity of the allosteric modulation in this protein and reveal a striking and unexpected link between different allosteric sites. Comparison of the FA site connections from D-NEMD in the glycosylated and non-glycosylated spike revealed that glycans do not qualitatively change the internal allosteric pathways but can facilitate the transmission of the structural changes within and between subunits.

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics
    Conor J Howard, Nathan S Abell ... Nathan B Lubock
    Research Article

    Deep Mutational Scanning (DMS) is an emerging method to systematically test the functional consequences of thousands of sequence changes to a protein target in a single experiment. Because of its utility in interpreting both human variant effects and protein structure-function relationships, it holds substantial promise to improve drug discovery and clinical development. However, applications in this domain require improved experimental and analytical methods. To address this need, we report novel DMS methods to precisely and quantitatively interrogate disease-relevant mechanisms, protein-ligand interactions, and assess predicted response to drug treatment. Using these methods, we performed a DMS of the melanocortin-4 receptor (MC4R), a G-protein-coupled receptor (GPCR) implicated in obesity and an active target of drug development efforts. We assessed the effects of >6600 single amino acid substitutions on MC4R’s function across 18 distinct experimental conditions, resulting in >20 million unique measurements. From this, we identified variants that have unique effects on MC4R-mediated Gαs- and Gαq-signaling pathways, which could be used to design drugs that selectively bias MC4R’s activity. We also identified pathogenic variants that are likely amenable to a corrector therapy. Finally, we functionally characterized structural relationships that distinguish the binding of peptide versus small molecule ligands, which could guide compound optimization. Collectively, these results demonstrate that DMS is a powerful method to empower drug discovery and development.